PLx Pharma Inc. Reports First Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
PLx Pharma Inc. (PLXP) Reports Q1 EPS Loss of $2.71, Revenues Beat
May 10, 2019 6:53 AM EDTPLx Pharma Inc. (NASDAQ: PLXP) reported Q1 EPS of ($2.71), $2.38 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $317.56 thousand versus the consensus estimate of $100 thousand.
Net loss attributable to common shareholders totaled $23.7 million, or ($2.71) per share, compared to net income of $5.0 million, or $0.57 per share, for the first quarter of 2018. This includes a non-cash charge of $12.8 million, or ($1.47) per share, related to the... More